Sorrento COVIDTRAP(STI-4398) Demonstrates in Preclinical Studies its Ability to Completely Inhibit SARS-CoV-2 Viral Infection In Vitro

Press/Media: Expert Comment

PeriodJun 5 2020

Media coverage

2

Media coverage